Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 203

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants

Open access
Shi, Xiaoguang, Liu, Rengyun, Basolo, Fulvio, Giannini, Riccardo, Shen, Xiaopei, Teng, Di, Guan, Haixia, Shan, Zhongyan, Teng, Weiping, Musholt, Thomas J., Al-Kuraya, Khawla, Fugazzola, Laura, Colombo, Carla, Kebebew, Electron, Jarzab, Barbara, Czarniecka, Agnieszka, Bendlova, Bela, Sykorova, Vlasta, Sobrinho-Simões, Manuel, Soares, Paula, Shong, Young Kee, Kim, Tae Yong, Cheng, Sonia, Asa, Sylvia L., Viola, David, Elisei, Rossella, Yip, Linwah, Mian, Caterina, Vianello, Federica, Wang, Yangang, Zhao, Shihua, Oler, Gisele, Cerutti, Janete M., Puxeddu, Efisio, Qu, Shen, Wei, Qing, Xu, Huixiong, O'Neill, Christine J., Sywak, Mark S., Clifton-Bligh, Roderick, Lam, Alfred K, Riesco-Eizaguirre, Garcilaso, Santisteban, Pilar, Yu, Hongyu, Tallini, Giovanni, Holt, Elizabeth H., Vasko, Vasily, Xing, Mingzhao · 2016 · The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Individualized management, incorporating papillary thyroid cancer (PTC) variant-specific risk, is conceivably a useful treatment strategy for PTC, which awaits comprehensive data demonstrating differential risks of PTC variants to support. OBJECTIVE: This study sought to establish the differential clinicopathological risk of major PTC variants: conventional PTC (CPTC), follicular-variant PTC (FVPTC), and tall-cell PTC (TCPTC). METHODS: This was a retrospective study of clinicopathological outcomes of 6282 PTC patients (4799 females and 1483 males) from 26 centers and The Cancer Genome Atlas in 14 countries with a median age of 44 years (interquartile range, 33-56 y) and median follow-up time of 37 months (interquartile range, 15-82 mo). RESULTS: The cohort consisted of 4702 (74.8%) patients with CPTC, 1126 (17.9%) with FVPTC, and 239 (3.8%) with TCPTC. The prevalence of high-risk parameters was significantly different among the three variants, including extrathyroidal invasion, lymph node metastasis, stages III/IV, disease recurrence, mortality, and the use (need) of radioiodine treatment (all P < .001), being highest in TCPTC, lowest in FVPTC, and intermediate in CPTC, following an order of TCPTC > CPTC ≫ FVPTC. Recurrence and mortality in TCPTC, CPTC, and FVPTC were 27.3 and 6.7%, 16.1 and 2.5%, and 9.1 and 0.6%, corresponding to events per 1000 person-years (95% confidence interval [CI]) of 92.47 (64.66-132.26) and 24.61 (12.31-49.21), 34.46 (30.71-38.66), and 5.87 (4.37-7.88), and 24.73 (18.34-33.35) and 1.68 (0.54-5.21), respectively. Mortality hazard ratios of CPTC and TCPTC over FVPTC were 3.44 (95% CI, 1.07-11.11) and 14.96 (95% CI, 3.93-56.89), respectively. Kaplan-Meier survival analyses showed the best prognosis in FVPTC, worst in TCPTC, and intermediate in CPTC in disease recurrence-free probability and disease-specific patient survival. This was particularly the case in patients at least 45 years old. CONCLUSION: This large multicenter study demonstrates differential prognostic risks of the three major PTC variants and establishes a unique risk order of TCPTC > CPTC ≫ FVPTC, providing important clinical implications for specific variant-based management of PTC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2015-2917

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 203

Metadata

Authors
Shi, X., Liu, R., Basolo, F., Giannini, R., Shen, X., Teng, D., Guan, H., Shan, Z., Teng, W., Musholt, T. J., Al-Kuraya, K., Fugazzola, L., Colombo, C., Kebebew, E., Jarzab, B., Czarniecka, A., Bendlova, B., Sykorova, V., Sobrinho-Simões, M., Soares, P., Shong, Y. K., Kim, T. Y., Cheng, S., Asa, S. L., Viola, D., Elisei, R., Yip, L., Mian, C., Vianello, F., Wang, Y., Zhao, S., Oler, G., Cerutti, J. M., Puxeddu, E., Qu, S., Wei, Q., Xu, H., O'Neill, C. J., Sywak, M. S., Clifton-Bligh, R., Lam, A. K., Riesco-Eizaguirre, G., Santisteban, P., Yu, H., Tallini, G., Holt, E. H., Vasko, V., & Xing, M.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2016-01
Volume
101
Issue
1
Pages
264-274
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2152737552
Cited by
203
References
1
FWCI
20.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants. https://app.cochat.ai/papers/10.1210/jc.2015-2917
The paper
Shi, X., Liu, R., Basolo, F., Giannini, R., Shen, X., Teng, D., Guan, H., Shan, Z., Teng, W., Musholt, T. J., Al-Kuraya, K., Fugazzola, L., Colombo, C., Kebebew, E., Jarzab, B., Czarniecka, A., Bendlova, B., Sykorova, V., Sobrinho-Simões, M., . . . Xing, M. (2016). Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2015-2917

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.